US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Biscolax Laxative

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1357-2019
Class II · Moderate risk Terminated

Pedia Relief Cough-Cold Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1356-2019
Class II · Moderate risk Terminated

Robafen DM Cough Sugar-Free Clear Cough Expectorant

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1355-2019
Class II · Moderate risk Terminated

Nasal Decongestant Spray Regular

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1354-2019
Class II · Moderate risk Terminated

Pseudoephedrine Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1353-2019
Class II · Moderate risk Terminated

Banophen Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1352-2019
Class II · Moderate risk Terminated

Robafen DM Syrup

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1351-2019
Class II · Moderate risk Terminated

Robafen AC Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1350-2019
Class II · Moderate risk Terminated

Robafen Cough Formula Expectorant

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1349-2019
Class II · Moderate risk Terminated

Children's Mapap Acetaminophen Liquid

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 0904-1985-20 D-1348-2019
Class II · Moderate risk Terminated

Allergy Liquid Antihistamine

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1347-2019
Class II · Moderate risk Terminated

Children's Acetaminophen Liquid

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1346-2019
Class II · Moderate risk Terminated

RisperiDONE Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc NDC 13668-589-06 D-1345-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1434-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1433-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1432-2019
Class II · Moderate risk Terminated

Pramipexole Dihydrochloride Tablets

Reason GMP Deviations; possible cross contamination of product due to cleaning procedure failure.

American Health Packaging D-1431-2019
Class II · Moderate risk Terminated

Amitiza

Reason Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.

Mallinckrodt Pharmaceuticals NDC 64764-240-60 D-1295-2019
Class II · Moderate risk Terminated

Amitiza

Reason Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.

Mallinckrodt Pharmaceuticals NDC 64764-080-60 D-1294-2019
Class I · High risk Terminated

Promacta

Reason Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.

Novartis Pharmaceuticals Corp. NDC 0078-0972-61 D-1309-2019
Class III · Low risk Terminated

QUIK-CARE Aerosol Foam Hand Sanitizer

Reason Incorrect/undeclared excipients: Hand sanitizer was made using the wrong alcohol raw material.

Ecolab Inc NDC 47593-490-82 D-1393-2019
Class II · Moderate risk Terminated

Anastrozole Tablets

Reason GMP Deviations: Potential cross contamination due to cleaning procedure failure.

American Health Packaging NDC 68001-155-04 D-1467-2019
Class II · Moderate risk Terminated

Anastrozole Tablets

Reason GMP Deviations: Potential cross contamination due to cleaning procedure failure.

American Health Packaging NDC 60687-112-21 D-1394-2019
Class II · Moderate risk Terminated

MethylPREDNISolone Tablets

Reason CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Zydus Pharmaceuticals USA Inc NDC 68382-917-11 D-1453-2019